دورية أكاديمية

IL-10 Counteracts IFN-γ to Alleviate Acute Lung Injury in a Viral-Bacterial Superinfection Model.

التفاصيل البيبلوغرافية
العنوان: IL-10 Counteracts IFN-γ to Alleviate Acute Lung Injury in a Viral-Bacterial Superinfection Model.
المؤلفون: McKelvey M; Department of Pathology and., Uddin MB; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas., Palani S; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas., Shao S; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas., Sun K; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas.
المصدر: American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2024 Jul; Vol. 71 (1), pp. 110-120.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 8917225 Publication Model: Print Cited Medium: Internet ISSN: 1535-4989 (Electronic) Linking ISSN: 10441549 NLM ISO Abbreviation: Am J Respir Cell Mol Biol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2000- : New York, NY : American Thoracic Society
Original Publication: [New York, NY : The Association, [c1989-
مواضيع طبية MeSH: Interleukin-10*/metabolism , Interleukin-10*/immunology , Acute Lung Injury*/virology , Acute Lung Injury*/immunology , Acute Lung Injury*/pathology , Acute Lung Injury*/microbiology , Interferon-gamma*/metabolism , Superinfection*/immunology , Superinfection*/virology , Disease Models, Animal*, Animals ; Mice ; Mice, Inbred C57BL ; Methicillin-Resistant Staphylococcus aureus/pathogenicity ; Coinfection/immunology ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/complications ; Orthomyxoviridae Infections/virology ; Staphylococcal Infections/immunology ; Mice, Knockout ; Influenza A virus/immunology ; Lung/virology ; Lung/pathology ; Lung/immunology ; Lung/metabolism
مستخلص: Immune activation is essential for lung control of viral and bacterial infection, but an overwhelming inflammatory response often leads to the onset of acute respiratory distress syndrome. IL-10 plays a crucial role in regulating the balance between antimicrobial immunity and immunopathology. In the present study, we investigated the role of IL-10 in acute lung injury induced by influenza A virus and methicillin-resistant Staphylococcus aureus coinfection. This unique coinfection model resembles patients with acute pneumonia undergoing appropriate antibiotic therapies. Using global IL-10 and IL-10 receptor gene-deficient mice, as well as in vivo neutralizing antibodies, we show that IL-10 deficiency promotes IFN-γ-dominant cytokine responses and triggers acute animal death. Interestingly, this extreme susceptibility is fully preventable by IFN-γ neutralization during coinfection. Further studies using mice with Il10ra deletion in selective myeloid subsets reveal that IL-10 primarily acts on mononuclear phagocytes to prevent IFN-γ/TNF-α hyperproduction and acute mortality. Importantly, this antiinflammatory IL-10 signaling is independent of its inhibitory effect on antiviral and antibacterial defense. Collectively, our results demonstrate a key mechanism of IL-10 in preventing hypercytokinemia and acute respiratory distress syndrome pathogenesis by counteracting the IFN-γ response.
التعليقات: Comment in: Am J Respir Cell Mol Biol. 2024 Jul;71(1):18-20. doi: 10.1165/rcmb.2024-0154ED. (PMID: 38701437)
References: Int J Infect Dis. 2012 May;16(5):e321-31. (PMID: 22387143)
Eur Respir J. 2009 Nov;34(5):1148-58. (PMID: 19541719)
J Immunol. 2018 Feb 15;200(4):1425-1433. (PMID: 29311363)
Immunology. 2000 Apr;99(4):523-31. (PMID: 10792499)
Gastroenterology. 2000 Dec;119(6):1473-82. (PMID: 11113068)
World J Gastroenterol. 2014 Oct 7;20(37):13501-11. (PMID: 25309080)
J Leukoc Biol. 2009 Jul;86(1):155-66. (PMID: 19386697)
Cell Rep. 2022 Mar 29;38(13):110565. (PMID: 35354043)
Eur J Immunol. 1993 Oct;23(10):2692-5. (PMID: 8405067)
J Immunol. 2003 Jan 15;170(2):1002-9. (PMID: 12517967)
J Clin Med. 2023 May 27;12(11):. (PMID: 37297908)
Toxicol Pathol. 2015 Dec;43(8):1074-92. (PMID: 26296628)
J Immunol. 2000 Sep 1;165(5):2783-9. (PMID: 10946310)
World J Gastroenterol. 2010 May 21;16(19):2440-2. (PMID: 20480533)
Nat Immunol. 2011 Apr;12(4):327-34. (PMID: 21297642)
Cell Mol Gastroenterol Hepatol. 2015 Mar 1;1(2):154-170. (PMID: 26000334)
Eur J Immunol. 1995 Apr;25(4):1129-32. (PMID: 7737285)
J Immunol. 2004 Jun 15;172(12):7603-9. (PMID: 15187140)
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1113-1121. (PMID: 28481621)
Eur Respir J. 2006 Apr;27(4):674-81. (PMID: 16585075)
Signal Transduct Target Ther. 2021 Dec 24;6(1):439. (PMID: 34952899)
J Clin Virol. 2016 Jul;80:12-9. (PMID: 27130980)
Am J Respir Crit Care Med. 1997 Apr;155(4):1469-73. (PMID: 9105096)
J Immunol. 1994 Feb 15;152(4):1821-9. (PMID: 8120391)
Immunity. 2018 Oct 16;49(4):666-677.e6. (PMID: 30291029)
Nat Commun. 2022 Dec 13;13(1):7703. (PMID: 36513690)
Cytokine. 2015 Jul;74(1):27-34. (PMID: 25481648)
Forensic Sci Med Pathol. 2022 Mar;18(1):4-19. (PMID: 34463916)
J Clin Med. 2023 Oct 09;12(19):. (PMID: 37835065)
Mucosal Immunol. 2014 Mar;7(2):440-8. (PMID: 24045574)
Nat Med. 2009 Mar;15(3):277-84. (PMID: 19234462)
J Immunol. 1997 Sep 15;159(6):2858-66. (PMID: 9300709)
Eur Respir J. 2006 Apr;27(4):669-70. (PMID: 16585073)
J Virol. 2010 May;84(10):5007-14. (PMID: 20200252)
Adv Immunol. 2014;122:177-210. (PMID: 24507158)
Pediatrics. 2008 Oct;122(4):805-11. (PMID: 18829805)
J Exp Med. 2016 Aug 22;213(9):1851-64. (PMID: 27526712)
Cell Rep. 2022 Mar 1;38(9):110456. (PMID: 35235782)
Emerg Infect Dis. 2016 Jul;22(7):1253-6. (PMID: 27315549)
J Immunol. 2021 Sep 1;207(5):1371-1376. (PMID: 34380647)
Front Immunol. 2021 Apr 28;12:638917. (PMID: 33995357)
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):6085-6092. (PMID: 30280795)
Infect Immun. 2019 Sep 19;87(10):. (PMID: 31383747)
J Immunol. 2009 Jun 15;182(12):7353-63. (PMID: 19494257)
Infect Immun. 2015 Dec;83(12):4662-72. (PMID: 26371131)
Intensive Care Med. 2020 Dec;46(12):2168-2183. (PMID: 33175277)
Immunity. 2006 Dec;25(6):941-52. (PMID: 17137799)
Front Immunol. 2022 Sep 20;13:1011132. (PMID: 36203588)
Am J Physiol Lung Cell Mol Physiol. 2000 May;278(5):L914-22. (PMID: 10781421)
Ann Intern Med. 1996 Aug 1;125(3):191-6. (PMID: 8686976)
Immunity. 2014 May 15;40(5):706-19. (PMID: 24792912)
J Immunol. 2019 Apr 1;202(7):2027-2034. (PMID: 30745458)
Cell. 2021 Jan 7;184(1):149-168.e17. (PMID: 33278357)
Respir Res. 2015 Feb 05;16:10. (PMID: 25651926)
Nat Genet. 2008 Nov;40(11):1319-23. (PMID: 18836448)
Intensive Care Med. 2020 Dec;46(12):2157-2167. (PMID: 33156382)
Mucosal Immunol. 2020 May;13(3):493-506. (PMID: 31932715)
معلومات مُعتمدة: R01 HL118408 United States HL NHLBI NIH HHS; R01 HL118408 United States NH NIH HHS
فهرسة مساهمة: Keywords: IL-10; S. aureus; acute lung injury; influenza; pneumonia
المشرفين على المادة: 130068-27-8 (Interleukin-10)
82115-62-6 (Interferon-gamma)
0 (IL10 protein, mouse)
تواريخ الأحداث: Date Created: 20240404 Date Completed: 20240701 Latest Revision: 20240707
رمز التحديث: 20240707
مُعرف محوري في PubMed: PMC11225870
DOI: 10.1165/rcmb.2023-0437OC
PMID: 38574279
قاعدة البيانات: MEDLINE
الوصف
تدمد:1535-4989
DOI:10.1165/rcmb.2023-0437OC